Sector: Pharmaceuticals & Biotechnology

Mid Cap

Marksans Pharma Share Price

MARKSANS

₹322.60

1.30(0.40%)

24th Aug 2026 | 11:40 AM

NSE : MARKSANS

Open Free Demat Account

Marksans Pharma Performance

Price Movement

₹322.60

₹317.90

₹324.60

↘ Today's Low↗ Today's High

1 Year Performance

₹322.60

₹155.00

₹345.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹324.60

Low₹317.90

Open at₹322.60

Prev Close₹321.30

Volumes8.57 L

Avg Price₹321.03

Lower Circuit₹257.05

Upper Circuit₹385.55

Historical Performance

3M High₹345.50

3M Low₹210.02

1 Yr High₹345.50

1 Yr Low₹155.00

3 Yr High₹358.70

3 Yr Low₹97.45

5 Yr High₹358.70

5 Yr Low₹38.60

Summary

As of 24-08-2026 11:57, Marksans Pharma Ltd. share price today is ₹0, with a change of ₹-321.30 (-100.00%) from the previous close of ₹321.3. The stock opened at ₹322.6 and traded between ₹317.9 and ₹324.6, with a total traded volume of 857239 shares. The company has a market capitalization of ₹14539.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹345.5 and ₹155, respectively.

Marksans Pharma Ltd. valuation metrics include a P/E ratio of 28.1, EPS of ₹9.22, and book value of ₹4.80. Profitability indicators show ROE of 13.83% along with a dividend yield of 0.3%. Marksans Pharma Ltd. has reported revenue of ₹3171.75 Cr and net profit of ₹516.75 Cr.

Marksans Pharma Ltd. technical indicators include Day RSI at 71.99, Day MFI at 92.98, Day ADX at 36.76. Additional indicators include Commodity Channel Index (CCI) at 131.1 and Williams %R at -19.8. Momentum indicators show Day MACD at 17.74, Day MACD Signal Line at 11.46, DayATR at 14.19. Rate of Change indicators for Marksans Pharma Ltd. include ROC125 at 79.92 and ROC21 at 25.62.

Exponential moving averages include EMA5 at ₹321.2, EMA10 at ₹307.8, EMA12 at ₹303.5, EMA20 at ₹291.6, EMA26 at ₹285.8, EMA50 at ₹269, EMA100 at ₹245.4, EMA200 at ₹225.4. Simple moving averages include SMA5 at ₹324.3, SMA10 at ₹302.7, SMA20 at ₹280.9, SMA30 at ₹276.5, SMA50 at ₹269.6, SMA100 at ₹234.3, SMA150 at ₹213.8, SMA200 at ₹207.1.

Support levels for Marksans Pharma are placed at First Support ₹321.80, Second Support ₹316.60, Third Support ₹309.85. Resistance levels are seen at First Resistance ₹333.75, Second Resistance ₹340.50, Third Resistance ₹345.70. Marksans Pharma Ltd. shareholding pattern shows promoter holding at 43.87%, FII holding at 17.47%, DII holding at 0%, public holding at 32.46%.

Marksans Pharma Fundamentals

Market Cap

High in industry

14,539.80 Cr.

PE Ratio (TTM)

Above industry Median

28.10

Dividend Yield

Below industry Median

0.30

Net Profit TTM

47.6% incr over last year

516.75

Net Profit Growth

47.6% incr over last year

516.75

PEG Ratio

Above industry Median

0.60

ROE

10% decr over last year

13.83

Operating Revenue TTM

3,171.75

Operating Revenue Growth

19.6% incr over last year

Book Value

Above industry Median

4.80

MFI

MFI strongly Overbought

92.98

RSI

RSI Overbought

71.99

EPS (TTM)

9.22

Debt to Equity

0.01

Face Value

Operating Profit Margin Qtr.

19.81

Operating Profit Qtr.

213.04

Net Profit Qtr.

157.17

Operating Revenue Qtr.

840.80

PB Ratio

4.80

Marksans Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	321.19	361.57	339.73	320.44	319.73
Operating Expense	239.08	255.58	264.28	248.37	249.68
Operating Profit	82.10	105.99	75.44	72.08	70.05
Depreciation	8.78	8.76	8.83	8.46	8.19
Interest	0.34	0.35	0.36	0.32	0.30
Tax	21.42	32.44	21.20	21.69	15.52
Net Profit	69.04	91.92	60.91	99.81	48.06

Marksans Pharma Technicals

Marksans Pharma Ltd. EMA & SMA

₹322.60

-4.40 (-1.35%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹321.2

Day EMA10 ₹307.8

Day EMA12 ₹303.5

Day EMA20 ₹291.6

Day EMA26 ₹285.8

Day EMA50 ₹269

Day EMA100 ₹245.4

Day EMA200 ₹225.4

Marksans Pharma Support and Resistance

Resistance

First Resistance₹333.75

Second Resistance₹340.50

Third Resistance₹345.70

Support

First Support₹321.80

Second Support₹316.60

Third Support₹309.85

Technical Indicators

Day RSI71.99

Day MFI92.98

Day ADX36.76

Day Commodity Channel Index131.10

William-19.80

Day MACD17.74

Day MACD Signal Line11.46

Day ATR14.19

Day ROC12579.92

Day ROC2125.62

Marksans Pharma Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	43.9	43.9	43.9	43.9	43.9	43.9
FII	22.2	19.9	16.9	8.1	16.8	17.5
DII	4.5	5.5	5.3	5.9	6.5	6.2
Public	29.4	30.7	33.9	42.1	32.8	32.5

Marksans Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	8.13 L	27.24 L	29.86%
Week	21.8 L	1.08 Cr	20.26%
1 Month	12.12 L	57.94 L	20.92%
6 Month	8.32 L	29.83 L	27.90%

Marksans Pharma SWOT Analysis

Strengths31

Weakness4

Opportunity1

Threats1

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 4 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Marksans Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
20 Aug, 2026	0.9	FINAL	20 Aug, 2026	Equity Share
01 Aug, 2025	0.8	FINAL	01 Aug, 2025	Equity Share
17 Sep, 2024	0.6	FINAL	17 Sep, 2024	Equity Share
07 Jun, 2023	0.5	FINAL	07 Jun, 2023	Equity Share
19 Aug, 2022	0.25	FINAL		Equity Share
15 Sep, 2021	0.25	FINAL		Equity Share
22 Sep, 2020	0.1	FINAL		Equity Share
19 Sep, 2019	0.05	FINAL		Equity Share
19 Sep, 2018	0.05	FINAL		Equity Share
19 Sep, 2017	0.05	FINAL		Equity Share

Marksans Pharma Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Strides Pharma Science Ltd.	FDC Ltd.	Shilpa Medicare Ltd.	Jubilant Pharmova Ltd.
Price (₹)	₹2,155.60	₹1,123.85	₹981.30	₹348.40	₹862.35	₹891.55
% Change	0.61%	1.08%	-0.50%	-0.06%	5.82%	1.27%
Revenue TTM (₹ Cr)	₹1,479.07	₹675.61	₹5,004.35	₹2,190.22	₹1,682.47	₹8,608.30
Net Profit TTM (₹ Cr)	₹199.03	₹182.64	₹613.50	₹292.56	₹297.32	₹352.10
PE TTM	65.20	71.50	14.40	19.20	54.00	39.40
1 Year Return	99.76	95.01	10.13	-28.07	91.54	-19.65
ROCE	31.54	24.22	21.66	15.67	11.36	6.81

Similar Stocks

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2500.00

-2.37%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1020.50

+1.84%

VIYASH

Viyash Scientific Ltd.

₹ 268.60

-2.66%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7265.00

-2.03%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 570.50

-1.49%

SANOFI

Sanofi India Ltd.

₹ 3315.00

-1.13%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.40

+0.41%

PGHL

Procter & Gamble Health Ltd.

₹ 5869.00

+0.69%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 515.35

+1.98%

SENORES

Senores Pharmaceuticals Ltd.

₹ 1587.30

+4.89%

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1528.80

-0.40%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4189.80

-0.77%

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 771.40

+2.85%

INNOVACAP

Innova Captab Ltd.

₹ 1080.60

-0.73%

BLUEJET

Blue Jet Healthcare Ltd

₹ 609.10

+2.17%

CONCORDBIO

Concord Biotech Ltd.

₹ 1541.70

-1.88%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 843.40

+3.26%

SUPRIYA

Supriya Lifescience Ltd.

₹ 806.45

+0.12%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1346.20

-0.35%

COHANCE

Cohance Lifesciences Ltd.

₹ 453.25

-2.11%

ERIS

Eris Lifesciences Ltd.

₹ 1315.70

-0.94%

SYNGENE

Syngene International Ltd.

₹ 401.80

-1.34%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 816.00

-0.70%

FAQ's on MARKSANS

What is the current share price of Marksans Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Marksans Pharma Ltd. is ₹ 322.6 on the NSE and ₹ 322.45 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Marksans Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Marksans Pharma Ltd. is approximately ₹ 14539.8 Cr.

What are the PE and PB ratios for Marksans Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Marksans Pharma Ltd. is 28.1, and the Price-to-Book (PB) ratio is 4.8.

What is the 52-Week High and Low for Marksans Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Marksans Pharma Ltd. shares was ₹ 345.5, and the lowest price was ₹ 155.

What is the current dividend yield for Marksans Pharma Ltd.?

As of 6 June 2025, the dividend yield for Marksans Pharma Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Marksans Pharma Ltd.?

Significant shareholdings in Marksans Pharma Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Marksans Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Marksans Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Marksans Pharma Ltd.?

Marksans Pharma Ltd. last declared a FINAL dividend of ₹ 0.9 per share for the financial period ending 2026. The record date was set as 2026-08-20, and the payment was/is scheduled around 2026-08-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy